We are monitoring the impact of COVID-19 on North America Stem Cell Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date June, 2021
ID: 11731
Share on
Share on

North America Stem Cell Therapy Market Research Report – Segmented By Type, Application, Cell Source, End-Users and Country (The United States, Canada and Rest of North America) - Industry Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: June, 2021
ID: 11731
Pages: 90

North America Stem Cell Therapy Market Size (2021 to 2026)

The size of the North American stem cell therapy market is estimated to be growing at a CAGR of 12.4% during the forecast period. The market growth is mainly driven by factors such as increasing stem cell research activities and increasing approvals of GMO-certified facilities for the manufacture of stem cells.

The need for new and better therapies for treating autoimmune, neurological, and cardiovascular diseases has resulted in a general increase in research activity and the availability of funds for cellular research. Compared with traditional therapeutic methods, the various advantages of stem cell therapy may make it preferable for treating degenerative diseases. The new solutions are based on minimally invasive techniques that generate healthy cells by replacing defective cells in the host.

Moreover, the growing popularity of personalized drugs further contributes to the growth of the North American stem cell therapy market. Researchers are discovering new procurement methods that can be further applied to develop personalized medicines. For example, stem cell therapies are developed using a small amount of a patient's blood or skin cell sample, reprogrammed to form new cells and tissues for transplantation. Therefore, with the application of these cells, possible personalized drugs can be developed.

However, several ethical problems are associated with the use of stem cells because these cells result from the destruction of the human embryo. The human embryo is considered a potential life, and its destruction is considered unethical even though it may save human life. These concerns about embryonic stem cells for stem cell therapy are limiting market growth factors globally.

Additionally, the high cost of stem cell therapy and other factors are expected to hamper the growth of the stem cell therapy market during the forecast period. Furthermore, the high cost of stem cell storage is a factor that is expected to hamper the growth of the market. Hence, the high cost associated with the storage of stem cells combined with the high cost of production is expected to hamper the market's growth, especially in emerging economies.

Impact of COVID-19 on the North American stem cell therapy market:

Coronavirus disease 2019 (COVID - 19) is an acute inflammatory respiratory infectious disease caused by SARS-CoV-2. Largely unknown before the outbreak began in early 2019, COVID-19 has gone from a regional crisis to a global pandemic in just a few weeks. As a result, the World Health Organization (WHO) declared COVID-19 as a pandemic in 2020 across the world.

Researchers have found new therapies and treatments to deal with this pandemic. For example, in recent years, stem cells have proven to be an effective method for treating lung disorders, including COVID-19.

Additionally, companies are focusing on developing therapies to reduce the stress associated with COVID-19. For example, in 2020, NoveCite and Novellus Therapeutics Limited partnered to develop and market NoveCite iPSC to treat acute respiratory distress syndrome (ARDS) associated with COVID-19. The process has multimodal immunomodulatory mechanisms of action, making it a promising therapy for treating acute respiratory diseases.

This research report on the North American stem cell therapy market has been segmented and sub-segmented based on the following categories.

 By Type:

  • Allogeneic
  • Autologous

By Application:

  • Musculoskeletal Disorders
  • Wounds and Injuries
  • Cardiovascular Diseases
  • Surgeries
  • Gastrointestinal Diseases
  • Other Applications

By Cell Source:

  • Adipose Tissue-Derived Mesenchymal Stem Cells
  • Bone Marrow-Derived Mesenchymal Stem Cells
  • Cord Blood/Embryonic Stem Cells
  • Other Cell Sources

By End User:

  • Hospitals
  • Clinics

By Country:

  • The United States
  • Canada
  • Rest of North America

Geographically, the large share of the North American stem cell therapy market is expected to account by the United States during the forecast period and can be mainly attributed to the increase in public-private funding and research grants to develop stem cell therapy products and safety testing.

In late 2019, Vertex Pharmaceuticals Inc, a US-based biopharmaceutical company, announced its decision to acquire Semma Therapeutics, a privately-held biotechnology company, for $ 960 million. The acquisition is expected to align with Vertex's strategy of investing in innovations that scientifically creates transformative medicine for critical patients. Semma Therapeutics is an American company dedicated to stem cell therapy for the treatment of diabetes.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the North American stem cell therapy market analyzed in this report are Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co., Ltd., Holostem Terapie Avanzate SRL, JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., and Allosource.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year, and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
        1. Secondary Research
        2. Primary Research
        3. Econometric Modelling
        4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1.  By Type
      1. Allogeneic Stem Cell Therapy
      2. Autologous
      3. Y-o-Y Growth Analysis, By Type
      4. Market Attractiveness Analysis, By Type
      5. Market Share Analysis, By Type
    2. By Application
      1. Musculoskeletal Disorders
      2. Wounds and Injuries
      3. Cardiovascular Diseases
      4. Surgeries
      5. Gastrointestinal Diseases
      6. Other Applications
      7. Y-o-Y Growth Analysis, By Application
      8. Market Attractiveness Analysis, By Application
      9. Market Share Analysis, By Application
    3. By Cell Source
      1. Adipose Tissue-Derived Mesenchymal Stem Cells
      2. Bone Marrow-Derived Mesenchymal Stem Cells
      3. Cord Blood/Embryonic Stem Cells
      4. Other Cell Sources
      5. Y-o-Y Growth Analysis, By Cell Source
      6. Market Attractiveness Analysis, By Cell Source
      7. Market Share Analysis, By Cell Source
    4. By End-User
      1. Hospitals
      2. Clinics
      3. Y-o-Y Growth Analysis, By End-User
      4. Market Attractiveness Analysis, By End-User
      5. Market Share Analysis, By End-Use
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Component
        3. By Delivery
        4. By End-User
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Component
        3. By Delivery
        4. By End-User
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Component
        3. By Delivery
        4. By End-User
    2. North America
      1. Introduction
      2. United States
      3. Canada
      4. Rest of North America
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Components and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. Osiris Therapeutics, Inc.
      1. Overview
      2. Component Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. MEDIPOST Co., Ltd.
    3. Anterogen Co., Ltd.
    4. Pharmicell Co., Ltd.
    5. Holostem Terapie Avanzate SRL
    6. JCR Pharmaceuticals Co., Ltd.
    7. NuVasive, Inc.
    8. RTI Surgical, Inc.
    9. Allosource
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Component Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. North America Stem Cell Therapy Market, By Type, From 2021 to 2026 (USD Million)
  2. North America Allogeneic Stem Cell Therapy Market, By Region, From 2021 to 2026 (USD Million)
  3. North America Autologous Market, By Region, From 2021 to 2026 (USD Million)
  4. North America Stem Cell Therapy Market, By Application, From 2021 to 2026 (USD Million)
  5. North America Musculoskeletal Disorders Market, By Region, From 2021 to 2026 (USD Million)
  6. North America Wounds and Injuries Market, By Region, From 2021 to 2026 (USD Million)
  7. North America Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Million)
  8. North America Surgeries Market, By Region, From 2021 to 2026 (USD Million)
  9. North America Gastrointestinal Diseases Market, By Region, From 2021 to 2026 (USD Million)
  10. North America Other Applications Market, By Region, From 2021 to 2026 (USD Million)
  11. North America Stem Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Million)
  12. North America Adipose Tissue-Derived Mesenchymal Stem Cells Market, By Region, From 2021 to 2026 (USD Million)
  13. North America Bone Marrow-Derived Mesenchymal Stem Cells Market, By Region, From 2021 to 2026 (USD Million)
  14. North America Cord Blood/Embryonic Stem Cells Market, By Region, From 2021 to 2026 (USD Million)
  15. North America Other Cell Sources Market, By Region, From 2021 to 2026 (USD Million)
  16. North America Stem Cell Therapy Market, By End User, From 2021 to 2026 (USD Million)
  17. North America Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  18. North America Clinics Market, By Region, From 2021 to 2026 (USD Million)
  19. United States Stem Cell Therapy Market, By Type, From 2021 to 2026 (USD Million)
  20. United States Stem Cell Therapy Market, By Application, From 2021 to 2026 (USD Million)
  21. United States Stem Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Million)
  22. United States Stem Cell Therapy Market, By End User, From 2021 to 2026 (USD Million)
  23. Canada Stem Cell Therapy Market, By Type, From 2021 to 2026 (USD Million)
  24. Canada Stem Cell Therapy Market, By Application, From 2021 to 2026 (USD Million)
  25. Canada Stem Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Million)
  26. Canada Stem Cell Therapy Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample